Skip to content
Screener

LeMaitre Vascular LMAT Total Cost of Revenue

Total Cost of Revenue at other companies

ITG
Integer HoldingsITGR
$329.99M+4.1%
Abbott logo
AbbottABT
$5.33B+9.7%
Baxter International logo
Baxter InternationalBAX
$1.81B+2.6%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$2.67B-7.2%
Edwards Lifesciences logo
Edwards LifesciencesEW
$392.4M+13.9%
Medtronic logo
MedtronicMDT
$3.4B+8.0%

Other financials

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.85B-12.4%
Enterprise value$1.84B-12.3%
P/E28.1×-16.6×
P/S-2.0×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line itemThree months ended / June 30, 2026Three months ended / June 30, 2025Six months ended / June 30, 2026Six months ended / June 30, 2025
Net sales$70,382$64,232$136,933$124,103
Cost of sales19,61819,25837,77337,709
Gross profit50,76444,97499,16086,394
Sales and marketing14,40814,89528,92329,107
General and administrative11,11010,39623,15620,883
Research and development4,8473,5418,9077,636
Total operating expenses30,36528,83260,98657,626
Income from operations20,39916,14238,17428,768

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's total cost of revenue?
LeMaitre Vascular (LMAT) reported total cost of revenue of $19.62M in Q2 2026.
How has LeMaitre Vascular's total cost of revenue changed year-over-year?
LeMaitre Vascular's total cost of revenue increased by 1.9% year-over-year, from $19.26M to $19.62M.
What is the long-term trend for LeMaitre Vascular's total cost of revenue?
Over 4 years (2021 to 2025), LeMaitre Vascular's total cost of revenue has grown at a 7.6% compound annual growth rate (CAGR), from $53.04M to $71.06M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about LeMaitre Vascular's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude